National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine | Vaccination | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Accepted for Publication: December 21, 2020.

Published Online: December 29, 2020. doi:10.1001/jama.2020.26419

Corresponding Author: Peter G. Szilagyi, MD, MPH, Department of Pediatrics, University of California, Los Angeles, 10833 LeConte, MC 175217, Los Angeles, CA 90095 (pszilagyi@mednet.ucla.edu).

Author Contributions: Drs Szilagyi and Kapteyn had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Szilagyi, Shah, Vizueta, Thomas, Kapteyn.

Acquisition, analysis, or interpretation of data: Szilagyi, Thomas, Shah, Cui, Vangala, Kapteyn.

Drafting of the manuscript: Szilagyi.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Szilagyi, Cui, Vangala.

Obtained funding: Szilagyi, Kapteyn.

Administrative, technical, or material support: Szilagyi, Vizueta.

Supervision: Szilagyi.

Conflict of Interest Disclosures: Dr Szilagyi reported receiving a grant from UCLA David Geffen School of Medicine—Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Award Program for personnel and statistical time. Dr Szilagyi also reported receiving funding from NIH NCATS UCLA CTSI during the conduct of this study. Dr Kapteyn reported receiving funding from University of Southern California (USC) for partial support for the USC survey team, grants from Bill & Melinda Gates Foundation for partial support for the UAS survey, grants from the National Institute on Aging for partial support for the UAS survey, and grants from National Science Foundation for partial support for the UAS during the conduct of the study. Dr Thomas reported receiving funding from USC and the National Institute on Aging. No other disclosures were reported.

Funding/Support: This work was supported by the UCLA David Geffen School of Medicine—Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research Award Program, the University of Southern California, the Bill & Melinda Gates Foundation, and by federal funds from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through the Clinical and Translational Science Awards (CTSA) Program (grant UL1TR001881), the National Institute on Aging (grant 5U01AG054580-03), and the National Science Foundation (grant 2028683).

Role of the Funder/Sponsor: The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Contributions: We thank Paul Simon, MD, and Rashmi Shetgiri, MD, of the Los Angeles County Department of Public Health for their input on an early draft of this article. Neither of the individuals received compensation for their contributions to the study.

References
1.
Reiter  PL , Pennell  ML , Katz  ML .  Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated?   Vaccine. 2020;38(42):6500-6507. doi:10.1016/j.vaccine.2020.08.043PubMedGoogle ScholarCrossref
2.
Fisher  KA , Bloomstone  SJ , Walder  J , Crawford  S , Fouayzi  H , Mazor  KM .  Attitudes toward a potential SARS-CoV-2 vaccine: a survey of US adults.   Ann Intern Med. 2020;173(12):964-973. doi:10.7326/M20-3569PubMedGoogle ScholarCrossref
3.
Malik  AA , McFadden  SM , Elharake  J , Omer  SB .  Determinants of COVID-19 vaccine acceptance in the US.   EClinicalMedicine. 2020;26:100495. doi:10.1016/j.eclinm.2020.100495PubMedGoogle Scholar
4.
Head  KJ , Kasting  ML , Sturm  LA , Hartsock  JA , Zimet  GD .  A national survey assessing SARS-CoV-2 vaccination intentions: implications for future public health communication efforts.   Science Communication. 2020;42(5):698-723. doi:10.1177/1075547020960463Google ScholarCrossref
5.
Kapteyn  A , Angrisani  M , Bennett  D ,  et al  Tracking the effect of the COVID-19 pandemic on American households.   Surv Res Methods-Ger. 2020;14(2):179-185.Google Scholar
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close